FDA Reports Results of Nationwide Infant Formula Testing - Top-Institutions - MDSpire

FDA Reports Results of Nationwide Infant Formula Testing

Federal testing survey examines chemical contaminant profiles across widely used products

  • By

  • Kathryn Wighton

  • April 29, 2026

  • 3 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    U.S. Food and Drug Administration (FDA)
    U.S. Food and Drug Administration (FDA)

    Silver Spring, MD

    Key Differentiators

    • Food Safety
    • Regulatory Science
    • Toxicology

  • #2

    Centers for Disease Control and Prevention (CDC) - National Center for Environmental Health
    Centers for Disease Control and Prevention (CDC) - National Center for Environmental Health

    Atlanta, GA

    Key Differentiators

    • Environmental Health
    • Toxicology
    • Pediatric Public Health

  • #3

    Children's Hospital of Philadelphia (CHOP) - Center for Pediatric Nutrition
    Children's Hospital of Philadelphia (CHOP) - Center for Pediatric Nutrition

    Philadelphia, PA

    Key Differentiators

    • Pediatric Nutrition
    • Infant Feeding
    • Clinical Research

  • #4

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Environmental Health Sciences
    • Toxicology
    • Epidemiology

  • #5

    University of California, Davis - Western Human Nutrition Research Center
    University of California, Davis - Western Human Nutrition Research Center

    Davis, CA

    Key Differentiators

    • Human Nutrition
    • Food Safety
    • Toxicology

Original Source(s)

FDA Reports Results of Nationwide Infant Formula Testing

  • by Kathryn Wighton

  • April 29, 2026

Related Content

Case Report: ETV6 c.744del gene mutation acute lymphoblastic leukemia in identical twins

Longitudinal patterns of postoperative brain oxygen saturation in children with congenital heart disease and postoperative delirium risk: a repeated measures analysis

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.